OrbiMed’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,525,654
Closed -$6.87M 136
2020
Q1
$6.87M Buy
2,525,654
+1,174,999
+87% +$3.9M 0.12% 95
2019
Q4
$1.62M Hold
1,350,655
0.02% 122
2019
Q3
$2.04M Hold
1,350,655
0.04% 107
2019
Q2
$5.43M Hold
1,350,655
0.09% 109
2019
Q1
$5.81M Hold
1,350,655
0.09% 104
2018
Q4
$7.77M Buy
1,350,655
+684,062
+103% +$5.05M 0.15% 92
2018
Q3
$9.04M Hold
666,593
0.11% 113
2018
Q2
$7.91M Sell
666,593
-200,000
-23% -$2.49M 0.1% 118
2018
Q1
$9.73M Sell
866,593
-1,048,067
-55% -$9.17M 0.12% 105
2017
Q4
$12.8M Hold
1,914,660
0.16% 97
2017
Q3
$15.7M Hold
1,914,660
0.15% 93
2017
Q2
$8.6M Hold
1,914,660
0.09% 101
2017
Q1
$10.6M Buy
1,914,660
+1,190,476
+164% +$5.21M 0.12% 95
2016
Q4
$2.93M Hold
724,184
0.04% 117
2016
Q3
$5.11M Hold
724,184
0.06% 116
2016
Q2
$5.9M Buy
724,184
+285,400
+65% +$2.69M 0.06% 110
2016
Q1
$3.57M Hold
438,784
0.04% 122
2015
Q4
$5.29M Buy
438,784
+262,314
+149% +$2.57M 0.05% 108
2015
Q3
$2.11M Sell
176,470
-4,234,716
-96% -$59.8M 0.02% 123
2015
Q2
$80.9M Buy
+4,411,186
New +$75.7M 0.68% 45

Other funds holding ADAP